naproxen has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athar, M; Chaudhary, SC; Elmets, CA; Kopelovich, L; Rana, M; Waseem, M; Xu, H | 1 |
| Ash, MM; Jolly, PS | 1 |
1 review(s) available for naproxen and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.
Topics: Aged; Anilides; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinoma, Basal Cell; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Interactions; Dysgeusia; Humans; Male; Myalgia; Naproxen; Pyridines; Skin Neoplasms | 2015 |
1 other study(ies) available for naproxen and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Naproxen Inhibits UVB-induced Basal Cell and Squamous Cell Carcinoma Development in Ptch1
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Humans; Mice, Hairless; Mice, Transgenic; Naproxen; Neoplasms, Radiation-Induced; Patched-1 Receptor; Skin Neoplasms; Ultraviolet Rays; Unfolded Protein Response | 2017 |